[go: up one dir, main page]

DK227183A - Fremgangsmaade til fremstilling af imidazo(1,2-c)-pyrazolo(3,4-e)pyrimidiner med den almene formel i - Google Patents

Fremgangsmaade til fremstilling af imidazo(1,2-c)-pyrazolo(3,4-e)pyrimidiner med den almene formel i Download PDF

Info

Publication number
DK227183A
DK227183A DK227183A DK227183A DK227183A DK 227183 A DK227183 A DK 227183A DK 227183 A DK227183 A DK 227183A DK 227183 A DK227183 A DK 227183A DK 227183 A DK227183 A DK 227183A
Authority
DK
Denmark
Prior art keywords
pyrazolo
pyrimidines
general formula
preparing imidazo
imidazo
Prior art date
Application number
DK227183A
Other languages
English (en)
Other versions
DK161968B (da
DK161968C (da
DK227183D0 (da
Inventor
Horace A Dewald
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK227183D0 publication Critical patent/DK227183D0/da
Publication of DK227183A publication Critical patent/DK227183A/da
Publication of DK161968B publication Critical patent/DK161968B/da
Application granted granted Critical
Publication of DK161968C publication Critical patent/DK161968C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK227183A 1982-05-24 1983-05-20 Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf DK161968C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38148482 1982-05-24
US06/381,484 US4469868A (en) 1982-05-24 1982-05-24 Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines

Publications (4)

Publication Number Publication Date
DK227183D0 DK227183D0 (da) 1983-05-20
DK227183A true DK227183A (da) 1983-11-25
DK161968B DK161968B (da) 1991-09-02
DK161968C DK161968C (da) 1992-02-03

Family

ID=23505215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK227183A DK161968C (da) 1982-05-24 1983-05-20 Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf

Country Status (22)

Country Link
US (1) US4469868A (da)
EP (1) EP0095289B1 (da)
JP (1) JPS58210087A (da)
KR (1) KR870000931B1 (da)
AR (1) AR240941A1 (da)
AT (1) ATE24510T1 (da)
AU (1) AU553708B2 (da)
CA (1) CA1210393A (da)
DE (1) DE3368635D1 (da)
DK (1) DK161968C (da)
ES (4) ES8407051A1 (da)
FI (1) FI74012C (da)
GR (1) GR79262B (da)
HK (1) HK102989A (da)
HU (1) HU187913B (da)
IE (1) IE55111B1 (da)
IL (1) IL68360A0 (da)
NO (1) NO160444C (da)
NZ (1) NZ204321A (da)
PH (1) PH18454A (da)
PT (1) PT76745B (da)
ZA (1) ZA832637B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
JP2008520749A (ja) * 2004-11-23 2008-06-19 レディ ユーエス セラピューティックス， インコーポレイテッド 新規二環式ヘテロ環化合物、その調製のためのプロセス、およびその新規二環式ヘテロ環化合物を含む組成物
EP1888534B1 (en) 2005-06-06 2017-07-26 Intra-Cellular Therapies, Inc. Organic compounds
JP5837278B2 (ja) 2006-12-05 2015-12-24 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規使用
AU2009322900A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
JP2012526810A (ja) 2009-05-13 2012-11-01 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物
WO2011153138A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
TWI606049B (zh) * 2011-04-21 2017-11-21 原真股份有限公司 新穎激酶抑制劑
US9637491B2 (en) 2012-10-19 2017-05-02 Origenis Gmbh Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
JP6549040B2 (ja) 2013-02-17 2019-07-24 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規使用
JP6437519B2 (ja) 2013-03-15 2018-12-12 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
ES2717688T3 (es) 2013-03-15 2019-06-24 Intra Cellular Therapies Inc Inhibidores de la PDE1 para uso en el tratamiento y/o prevención de lesiones de SNC, y enfermedades, trastornos o lesiones de SNP
EP3157926B1 (en) 2014-06-20 2019-05-15 Intra-Cellular Therapies, Inc. Organic compounds
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
US10131671B2 (en) 2014-08-07 2018-11-20 Intra-Cellular Therapies, Inc. Organic compounds
RU2711442C2 (ru) 2014-09-17 2020-01-17 Интра-Селлулар Терапиз, Инк. Соединения и способы
WO2017172795A1 (en) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel compositions and methods
JP7134168B6 (ja) 2016-09-12 2024-02-02 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規使用
WO2019152697A1 (en) 2018-01-31 2019-08-08 Intra-Cellular Therapies, Inc. Novel uses

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3313815A (en) * 1964-05-04 1967-04-11 Sterling Drug Inc 8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same
US3309369A (en) * 1966-04-11 1967-03-14 Wander Ag Dr A Imidazo- and pyrimido-quinazolines
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
DE2058501A1 (de) * 1970-11-27 1972-05-31 Bayer Ag Verfahren zur Herstellung von neuen N-verbrueckten bicyclischen Heteroaromaten
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
US3984556A (en) * 1973-01-19 1976-10-05 Sandoz, Inc. Alkyl-substituted-tricyclic quinazolinones for lowering blood pressure
JPS516993A (en) * 1974-07-05 1976-01-20 Dainippon Pharmaceutical Co Adeninjudotaino seiho
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation
US4206123A (en) * 1977-10-31 1980-06-03 Mccall John M Isothiochroman
US4250181A (en) * 1977-10-31 1981-02-10 The Upjohn Company Methods of treating psychosis
US4247553A (en) * 1977-10-31 1981-01-27 The Upjohn Company Methods of treating psychosis
US4192803A (en) * 1978-09-15 1980-03-11 American Cyanamid Company 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives
IE48979B1 (en) * 1978-11-01 1985-06-26 Wellcome Found Carbazoles
CH643263A5 (de) * 1979-05-11 1984-05-30 Sandoz Ag Benzodiazepine, ihre herstellung und verwendung.
HU178523B (en) * 1979-05-18 1982-05-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing new pyrazolo-quinazoline derivatives
US4230707A (en) * 1979-08-27 1980-10-28 Warner-Lambert Company Oxo-pyrido[1,2-a]thienopyrimidine compounds and methods for their production
US4358456A (en) * 1980-05-03 1982-11-09 John Wyeth & Brother Limited Antipsychotic piperidinomethyl-indole derivatives
US4396770A (en) * 1982-04-09 1983-08-02 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4374245A (en) * 1982-04-09 1983-02-15 Hoechst-Roussel Pharmaceuticals Inc. 8-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
US4390544A (en) * 1982-04-09 1983-06-28 Hoechst-Roussel Pharmaceuticals Inc. {1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(2-oxo-1-benzimidazolinyl}p
US4415581A (en) * 1982-04-09 1983-11-15 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines to treat psychoses
US4409230A (en) * 1982-04-09 1983-10-11 Hoechst-Roussel Pharmaceuticals Inc. Pharmaceutical compositions and methods employing 8-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro-[4.]decan-4-one and derivatives thereof
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol

Also Published As

Publication number Publication date
CA1210393A (en) 1986-08-26
NO160444C (no) 1989-04-19
AU553708B2 (en) 1986-07-24
FI74012C (fi) 1987-12-10
JPS58210087A (ja) 1983-12-07
DK161968B (da) 1991-09-02
ES522617A0 (es) 1984-09-01
ES529371A0 (es) 1985-07-01
ES8506004A1 (es) 1985-06-16
US4469868A (en) 1984-09-04
DE3368635D1 (en) 1987-02-05
IL68360A (en) 1986-10-31
IE830822L (en) 1983-11-24
ES529372A0 (es) 1985-06-16
PT76745A (en) 1983-06-01
HU187913B (en) 1986-03-28
ES8407051A1 (es) 1984-09-01
ES8506315A1 (es) 1985-07-01
EP0095289A3 (en) 1984-09-05
GR79262B (da) 1984-10-22
ES529373A0 (es) 1985-06-16
IL68360A0 (en) 1986-10-31
DK161968C (da) 1992-02-03
HK102989A (en) 1990-01-05
EP0095289B1 (en) 1986-12-30
EP0095289A2 (en) 1983-11-30
ES8506019A1 (es) 1985-06-16
AR240941A2 (es) 1991-03-27
ATE24510T1 (de) 1987-01-15
ZA832637B (en) 1984-01-25
IE55111B1 (en) 1990-06-06
AR240941A1 (es) 1991-03-27
PT76745B (en) 1986-04-21
FI74012B (fi) 1987-08-31
KR870000931B1 (ko) 1987-05-11
FI831742L (fi) 1983-11-25
NO831792L (no) 1983-11-25
NZ204321A (en) 1986-06-11
DK227183D0 (da) 1983-05-20
JPH0320395B2 (da) 1991-03-19
PH18454A (en) 1985-07-18
AU1342783A (en) 1983-12-01
FI831742A0 (fi) 1983-05-18
KR840004756A (ko) 1984-10-24
NO160444B (no) 1989-01-09

Similar Documents

Publication Publication Date Title
DK227183A (da) Fremgangsmaade til fremstilling af imidazo(1,2-c)-pyrazolo(3,4-e)pyrimidiner med den almene formel i
DK120783A (da) Fremgangsmaade til fremstilling af substituerede 1h-pyrazolo(1,5-a)pyrimidiner
NO874302L (no) Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo(1,5-a)pyrimidiner.
NO834711L (no) Imidazo(1,5-a)pyridin-derivater
DK133482A (da) Fremgangsmaade til fremstilling af imidazo(1,2-a)pyrimidiner
DK390583A (da) Fremgangsmaade til fremstilling af imidazo(1,2-a)pyrimidiner
AR229519A1 (es) Procedimiento de preparacion de derivados de 2,3-dihidro-9-fenil-1h-pirazolo(1,2-a)-indazolio
PT71197A (en) Process for the preparation of substituted pyrido/1,2-a/pyrimidines
PT75240B (en) Process for the preparation of substituted thiazolo <3,2-a>pyrimidines
FI834664A0 (fi) Substituerade imidazo(1,5-a)pyridiner
DK44383D0 (da) Fremgangsmade til fremstilling af substituerede 1,3,4-thiadiazolo(3,2-a)pyrimidiner
DK584484D0 (da) Kemisk fremgangsmaade til fremstilling af antibiotikum l 17054
DK96379A (da) Fremgangsmaade til fremstilling af disubstituerede 2,3-dihydroimidazo (1,2-c)-pyrimidiner
DK367388D0 (da) Til fremstilling af hoejredrejende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)thiazol-7-carboxylsyre
DK133883A (da) Fremgangsmaade til fremstilling af substituerede ethenylderivater af 1h-pyrazolo(1,5-a)pyrimidin
PT75244A (de) Verfahren zur herstellung von 5,11-dihydro-6h-pyrido <2,3-b>-<1,4> benzodiazepin-6-onen
IT8048792A0 (it) Composti di imidazo (1,5-d)as-triazin-4(3h)-oni e -tioni sostituiti e procedimento per laloro preparazione
FI821709A (fi) Foerfarande foer framstaellning av pyrido-/2,3-b/-/1,4/-benzodiazepiner
GB2078224B (en) The preparation of indolo(2'3';3'4)-pyrido-(2,1-b)quinazolin-5-ones
ATA416882A (de) Verfahren zur herstellung von neuen spiro-derivaten des pyrazolo (1,5-d) (1,2,4) triazin-ring-systems
PL238393A2 (en) Method of manufacture of novel 2-beta-isopropyloaminoethyl-8-hydroxy-9-benzoylaminoperhydropyrazin/1,2-c/pyrimidin-1,6-dione
ES485288A0 (es) Procedimiento de preparacion de nuevas imidazo (1,5-d) as- triazina-4 (3h)-onas y -tionas
GR860095B (en) Method for the preparation of novel heterocyclic compounds
JPS5321196A (en) Novel nitrogen-containing heterocyclic compounds and their preparation

Legal Events

Date Code Title Description
PBP Patent lapsed